Skip to main content
OTCMKTS:NEWUF

Newtopia Competitors

$0.38
0.00 (-0.24 %)
(As of 05/14/2021 10:08 PM ET)
Add
Compare
Today's Range
$0.38
$0.38
50-Day Range N/A
52-Week Range
$0.32
$1.28
Volume5,100 shs
Average Volume17,095 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Newtopia (OTCMKTS:NEWUF) Vs. BNVIF, CNONF, DOCRF, EVAHF, EWLL, and FORA

Should you be buying NEWUF stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to Newtopia, including Binovi Technologies (BNVIF), CannaOne Technologies (CNONF), CloudMD Software & Services (DOCRF), EGF Theramed Health (EVAHF), eWellness Healthcare (EWLL), and Forian (FORA).

Newtopia (OTCMKTS:NEWUF) and Binovi Technologies (OTCMKTS:BNVIF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership.

Profitability

This table compares Newtopia and Binovi Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NewtopiaN/AN/AN/A
Binovi TechnologiesN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Newtopia and Binovi Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Newtopia00103.00
Binovi Technologies0000N/A

Newtopia currently has a consensus target price of $1.30, suggesting a potential upside of 242.11%. Given Newtopia's higher probable upside, research analysts clearly believe Newtopia is more favorable than Binovi Technologies.

Earnings & Valuation

This table compares Newtopia and Binovi Technologies' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewtopiaN/AN/AN/AN/AN/A
Binovi TechnologiesN/AN/AN/AN/AN/A

Summary

Newtopia beats Binovi Technologies on 2 of the 2 factors compared between the two stocks.

CannaOne Technologies (OTCMKTS:CNONF) and Newtopia (OTCMKTS:NEWUF) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership and analyst recommendations.

Earnings & Valuation

This table compares CannaOne Technologies and Newtopia's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CannaOne TechnologiesN/AN/AN/AN/AN/A
NewtopiaN/AN/AN/AN/AN/A

Profitability

This table compares CannaOne Technologies and Newtopia's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CannaOne TechnologiesN/AN/AN/A
NewtopiaN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for CannaOne Technologies and Newtopia, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CannaOne Technologies0000N/A
Newtopia00103.00

Newtopia has a consensus price target of $1.30, suggesting a potential upside of 242.11%. Given Newtopia's higher probable upside, analysts plainly believe Newtopia is more favorable than CannaOne Technologies.

Summary

Newtopia beats CannaOne Technologies on 2 of the 2 factors compared between the two stocks.

CloudMD Software & Services (OTCMKTS:DOCRF) and Newtopia (OTCMKTS:NEWUF) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, profitability and analyst recommendations.

Valuation & Earnings

This table compares CloudMD Software & Services and Newtopia's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CloudMD Software & ServicesN/AN/AN/AN/AN/A
NewtopiaN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations for CloudMD Software & Services and Newtopia, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CloudMD Software & Services00203.00
Newtopia00103.00

CloudMD Software & Services currently has a consensus price target of $3.3750, suggesting a potential upside of 112.26%. Newtopia has a consensus price target of $1.30, suggesting a potential upside of 242.11%. Given Newtopia's higher probable upside, analysts plainly believe Newtopia is more favorable than CloudMD Software & Services.

Profitability

This table compares CloudMD Software & Services and Newtopia's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CloudMD Software & ServicesN/AN/AN/A
NewtopiaN/AN/AN/A

Newtopia (OTCMKTS:NEWUF) and EGF Theramed Health (OTCMKTS:EVAHF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, valuation and dividends.

Earnings & Valuation

This table compares Newtopia and EGF Theramed Health's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewtopiaN/AN/AN/AN/AN/A
EGF Theramed HealthN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings for Newtopia and EGF Theramed Health, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Newtopia00103.00
EGF Theramed Health0000N/A

Newtopia presently has a consensus price target of $1.30, suggesting a potential upside of 242.11%. Given Newtopia's higher possible upside, research analysts clearly believe Newtopia is more favorable than EGF Theramed Health.

Profitability

This table compares Newtopia and EGF Theramed Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NewtopiaN/AN/AN/A
EGF Theramed HealthN/AN/AN/A

Summary

Newtopia beats EGF Theramed Health on 2 of the 2 factors compared between the two stocks.

Newtopia (OTCMKTS:NEWUF) and eWellness Healthcare (OTCMKTS:EWLL) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, valuation and risk.

Profitability

This table compares Newtopia and eWellness Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NewtopiaN/AN/AN/A
eWellness HealthcareN/AN/AN/A

Valuation and Earnings

This table compares Newtopia and eWellness Healthcare's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewtopiaN/AN/AN/AN/AN/A
eWellness HealthcareN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and price targets for Newtopia and eWellness Healthcare, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Newtopia00103.00
eWellness Healthcare0000N/A

Newtopia currently has a consensus target price of $1.30, suggesting a potential upside of 242.11%. Given Newtopia's higher possible upside, equities research analysts plainly believe Newtopia is more favorable than eWellness Healthcare.

Summary

Newtopia beats eWellness Healthcare on 2 of the 2 factors compared between the two stocks.

Newtopia (OTCMKTS:NEWUF) and Forian (NASDAQ:FORA) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, valuation and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for Newtopia and Forian, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Newtopia00103.00
Forian0000N/A

Newtopia currently has a consensus target price of $1.30, suggesting a potential upside of 242.11%. Given Newtopia's higher possible upside, equities research analysts plainly believe Newtopia is more favorable than Forian.

Valuation and Earnings

This table compares Newtopia and Forian's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewtopiaN/AN/AN/AN/AN/A
ForianN/AN/AN/AN/AN/A

Profitability

This table compares Newtopia and Forian's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NewtopiaN/AN/AN/A
ForianN/AN/AN/A

Summary

Newtopia beats Forian on 2 of the 2 factors compared between the two stocks.


Newtopia Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.05-4.2%$0.00N/A0.00Gap Up
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$1.15-4.3%$0.00N/A0.00
CloudMD Software & Services logo
DOCRF
CloudMD Software & Services
1.7$1.59-1.9%$0.00N/A0.00
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.08-5.0%$0.00N/A0.00Gap Down
EWLL
eWellness Healthcare
0.6$0.00-18.8%$0.00N/A0.00
FORA
Forian
0.3$9.39-0.9%$0.00N/A0.00
M3 logo
MTHRF
M3
1.0$64.76-9.3%$0.00N/A0.00Gap Down
PANHF
Ping An Healthcare and Technology
1.0$10.95-0.7%$0.00N/A0.00News Coverage
Gap Up
Pro Medicus logo
PMCUF
Pro Medicus
0.5$32.00-2.4%$0.00N/A0.00High Trading Volume
Gap Up
CBIIF
Skylight Health Group
0.0$1.32-5.3%$0.00N/A0.00High Trading Volume
Gap Up
UCBB
US-China Biomedical Technology
0.3$0.11-7.1%$0.00N/A0.00High Trading Volume
Gap Up
WELL Health Technologies logo
WLYYF
WELL Health Technologies
1.8$5.63-1.6%$0.00N/A0.00
This page was last updated on 5/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.